Vocabria

Vocabria (cabotegravir) is an oral medication used in HIV treatment and prevention. It belongs to the integrase inhibitor class and is prescribed alongside other antiretrovirals. This page covers general information, uses, and handling notes for potential users.

Vocabria (cabotegravir) is primarily used to treat HIV-1 infection as part of combination therapy. It may also be prescribed for pre-exposure prophylaxis (PrEP) in adults at risk of HIV exposure. The medication works by blocking integrase, an enzyme the virus needs to replicate. It is not a standalone cure but helps manage the condition when taken as directed.

Common effects of Vocabria include mild to moderate gastrointestinal symptoms such as nausea or diarrhea. Some users report headaches or fatigue, especially when starting treatment. These effects are usually temporary and may lessen over time. As with any medication, individual responses can vary.

Vocabria should be stored in a cool, dry place away from direct sunlight and out of reach of children. Do not use if the packaging is damaged or the tablets show signs of tampering. Keep the medication in its original container with the lid tightly closed. Always check the expiry date before use.

Vocabria may interact with certain medications, including rifampin, carbamazepine, and St. John’s wort. These interactions can affect how the drug works or increase side effects. Alcohol and grapefruit products may also influence its effectiveness. Always inform your healthcare provider about all medications and supplements you are taking.